Clinical trials need an overhaul – and AI is the solution.

Is blockchain truly the solution the industry's been looking for?

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Will the antibiotic apocalypse kill us all?

Do you want to share the story behind your technology in a future issue of The Medicine Maker?

Will Gene's Supplier Exchange Program and eData skills get him what he wants?

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?